Page last updated: 2024-10-25

cimetidine and Protein-Losing Enteropathies

cimetidine has been researched along with Protein-Losing Enteropathies in 7 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelly, DG1
Miller, LJ1
Malagelada, JR1
Huizenga, KA1
Markowitz, H1
Wood, JG1
Davenport, HW1
Bayerdörffer, E1
Ritter, MM1
Hatz, R1
Brooks, W1
Stolte, M1
Becker, K1
Frieling, T1
Erckenbrecht, JF1
Frederiksen, HJ2
Olsen, N2
Krag, E2
Henriksen, JH1
Sasaki, E1
Toyonaga, A1
Murayama, S1
Kuboyama, S1
Sasaki, S1
Inuzuka, S1
Tsuruta, O1
Ikeda, H1
Ito, H1
Sakisaka, S1

Reviews

1 review available for cimetidine and Protein-Losing Enteropathies

ArticleYear
[Protein-losing syndrome of the gastrointestinal tract].
    Deutsche medizinische Wochenschrift (1946), 2001, Oct-26, Volume: 126, Issue:43

    Topics: Adult; Algorithms; Anti-Ulcer Agents; Child; Cholinergic Agents; Cimetidine; Clinical Trials as Topi

2001

Other Studies

6 other studies available for cimetidine and Protein-Losing Enteropathies

ArticleYear
Giant hypertrophic gastropathy (Ménétrier's disease): pharmacologic effects on protein leakage and mucosal ultrastructure.
    Gastroenterology, 1982, Volume: 83, Issue:3

    Topics: Adult; Aged; Albumins; Bethanechol; Bethanechol Compounds; Chromium Radioisotopes; Cimetidine; Femal

1982
Measurement of canine gastric vascular permeability to plasma proteins in the normal and protein-losing states.
    Gastroenterology, 1982, Volume: 82, Issue:4

    Topics: Animals; Blood Proteins; Capillary Permeability; Cimetidine; Dithiothreitol; Dogs; Fibrinogen; Gastr

1982
Ménétrier's disease and Helicobacter pylori.
    The New England journal of medicine, 1993, Jul-01, Volume: 329, Issue:1

    Topics: Adult; Amoxicillin; Cimetidine; Female; Gastritis, Hypertrophic; Helicobacter Infections; Helicobact

1993
[Cimetidine treatment of Ménétrier's syndrome].
    Ugeskrift for laeger, 1978, Feb-06, Volume: 140, Issue:6

    Topics: Cimetidine; Gastritis; Guanidines; Humans; Hypertrophy; Male; Middle Aged; Protein-Losing Enteropath

1978
Cimetidine treatment of protein-losing gastropathy (Ménétrier's disease). A clinical and pathophysiological study.
    Scandinavian journal of gastroenterology, 1978, Volume: 13, Issue:5

    Topics: Cimetidine; Guanidines; Humans; Intestinal Absorption; Male; Membrane Potentials; Middle Aged; Prote

1978
[A case report of Menetrier's disease developed in a patient with ulcerative colitis].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1991, Volume: 88, Issue:1

    Topics: Aged; alpha 1-Antitrypsin; Cimetidine; Colitis, Ulcerative; Feces; Gastric Juice; Gastritis, Hypertr

1991